Baxter Bros Inc Illumina, Inc. Transaction History

Baxter Bros Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	BUY	$127.73 - $147.2 $214,586 - $247,295	1,680 New	1,680 $230,000
Q1 2023 May 15, 2023	SELL	$193.75 - $232.55 $11,625 - $13,953	-60 Reduced 3.45%	1,680 $390,000
Q3 2022 Nov 10, 2022	BUY	$177.23 - $227.44 $10,633 - $13,646	60 Added 3.57%	1,740 $332,000
Q4 2020 Jan 25, 2021	SELL	$292.7 - $370.96 $4,975 - $6,306	-17 Reduced 1.0%	1,680 $622,000
Q3 2020 Nov 05, 2020	BUY	$268.51 - $400.74 $4,564 - $6,812	17 Added 1.01%	1,697 $525,000
Q2 2020 Jul 31, 2020	SELL	$256.46 - $373.01 $41,033 - $59,681	-160 Reduced 8.7%	1,680 $622,000
Q1 2020 Apr 17, 2020	SELL	$209.2 - $335.53 $330,536 - $530,137	-1,580 Reduced 46.2%	1,840 $503,000
Q4 2019 Jan 10, 2020	BUY	$288.29 - $335.49 $985,951 - $1.15 Million	3,420 New	3,420 $1.14 Million

852

138M

1.41M

1.66M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $20.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

Stay updated on Baxter Bros Inc with notifications on news.